Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic? E. Andrew TownsendMatthew L. Banks Leading Article 04 April 2020 Pages: 449 - 461
Safety and Efficacy of Ubrogepant for the Acute Treatment of Episodic Migraine: A Meta-Analysis of Randomized Clinical Trials Yanbo YangMingjia ChenZhong Wang Systematic Review 19 March 2020 Pages: 463 - 471
Comparative Tolerability of Dopamine D2/3 Receptor Partial Agonists for Schizophrenia Nicholas KeksJudith HopeGraham Meadows Review Article 03 April 2020 Pages: 473 - 507
The Efficacy and Safety of Concomitant Psychotropic Medication and Electroconvulsive Therapy (ECT) A. Umair JanjuaAmitha L. DhingraWilliam M. McDonald Review Article 27 April 2020 Pages: 509 - 520
Predicted Cellular and Molecular Actions of Lithium in the Treatment of Bipolar Disorder: An In Silico Study Hadi NajafiMehdi TotonchiMajid Sadeghizadeh Original Research Article 18 April 2020 Pages: 521 - 533
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab Eleonora SgarlataClara Grazia ChisariFrancesco Patti Original Research Article 27 March 2020 Pages: 535 - 543
Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring Anemone von BlombergLara KayAdam Strzelczyk Original Research Article Open access 26 March 2020 Pages: 545 - 553
Transnasal Revolution? The Promise of Midazolam Spray to Prevent Seizure Clusters Raoul SutterPeter W. Kaplan Commentary 03 April 2020 Pages: 555 - 557